IDH1 and central nervous system cancer: A 13C metabolic flux analysis [10] on a panel of IDH-mutated glioma cell lines observed increased oxidative metabolism in the Krebs cycle as well as reduced tumor growth rates under hypoxic conditions, suggesting IDH1 mutant gliomas prefer a more oxygenated microenvironment for proliferation.